Trial of tDCS in adolescents with OCD as early augmentatio
Phase 3
Completed
- Conditions
- Health Condition 1: F422- Mixed obsessional thoughts and acts
- Registration Number
- CTRI/2021/12/039002
- Lead Sponsor
- King Georges Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 21
Inclusion Criteria
1. Informed consent to participate in the study
2. Diagnosed with OCD (DSM-5)
3. Symptomatic (CY-BOCS Score >13)
4. Drug naïve (At least drug free since 1 month)
Exclusion Criteria
1. Medical comorbidities that need priority management.
2. Any contraindication to tDCS
3. Any other psychiatric comorbidity (except Major Depressive Disorder)
4. Intellectual disability
• History of treatment resistant OCD
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method